María Laura Sbaraglini
María Laura Sbaraglini
Docente de anatomía e histología, facultad de ciencias exactas, unlp
Dirección de correo verificada de biol.unlp.edu.ar
TítuloCitado porAño
Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats
C Sedlinsky, MS Molinuevo, AM Cortizo, MJ Tolosa, JI Felice, ...
European journal of pharmacology 668 (3), 477-485, 2011
442011
Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning
LN Alberca, ML Sbaraglini, D Balcazar, L Fraccaroli, C Carrillo, ...
Journal of computer-aided molecular design 30 (4), 305-321, 2016
192016
Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells
ML Sbaraglini, MS Molinuevo, C Sedlinsky, L Schurman, AD McCarthy
European journal of pharmacology 727, 8-14, 2014
182014
Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease
ML Sbaraglini, CL Bellera, L Fraccaroli, L Larocca, C Carrillo, A Talevi, ...
International journal of antimicrobial agents 48 (1), 91-95, 2016
152016
Neglected tropical protozoan diseases: drug repositioning as a rational option
M Laura Sbaraglini, M Cristina Vanrell, C Leticia Bellera, G Benaim, ...
Current topics in medicinal chemistry 16 (19), 2201-2222, 2016
132016
Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro/in vivo evaluation
SS Montoto, ML Sbaraglini, A Talevi, M Couyoupetrou, M Di Ianni, ...
Colloids and Surfaces B: Biointerfaces 167, 73-81, 2018
122018
Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro/in vivo evaluation
SS Montoto, ML Sbaraglini, A Talevi, M Couyoupetrou, M Di Ianni, ...
Colloids and Surfaces B: Biointerfaces 167, 73-81, 2018
122018
Cascade ligand-and structure-based virtual screening to identify new trypanocidal compounds inhibiting putrescine uptake.
LN Alberca, ML Sbaraglini, JF Morales, R Dietrich, MD Ruiz, ...
Frontiers in Cellular and Infection Microbiology 8, 173, 2018
52018
Hybrid compounds as anti-infective agents
ML Sbaraglini, A Talevi
Current topics in medicinal chemistry 17 (9), 1080-1095, 2017
32017
Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs
GA Islan, ME Ruiz, JF Morales, ML Sbaraglini, AV Enrique, G Burton, ...
Journal of Materials Chemistry B 5 (17), 3132-3144, 2017
32017
Knowledge-based drug repurposing: a rational approach towards the identification of novel medical applications of known drugs
CL Bellera, ME Di Ianni, ML Sbaraglini, EA Castro, LE Bruno-Blanch, ...
Frontiers in computational chemistry, 44-81, 2015
32015
Modern approaches for the discovery of anti-infectious drugs for the treatment of neglected diseases
CL Bellera, ML Sbaraglini, A Talevi
Current topics in medicinal chemistry 18 (5), 369-381, 2018
12018
Enseñanza-aprendizaje de anatomía e histología a través de problemas. Thc para el estudio integrado de los aparatos digestivo, respiratorio y circulatorio: resistencias …
M Ibáñez Shimabukuro, IS Rolny, ML Sbaraglini, MV Gangoiti, JI Felice, ...
I Jornadas sobre Enseñanza y Aprendizaje en el Nivel Superior en Ciencias …, 2017
12017
Alcances y desafíos en la implementación de una cátedra virtual en la enseñanza y aprendizaje de Anatomía e Histología
JI Felice, M Ibáñez, ML Sbaraglini, F Speroni Aguirre
III Jornadas de TIC e Innovación en el Aula (La Plata, 2015), 2015
12015
Combined therapy with Benznidazole and repurposed drugs Clofazimine and Benidipine for chronic Chagas disease
ML Sbaraglini, CL Bellera, JQ Braghini, Y Areco, C Miranda, C Carrillo, ...
European Journal of Medicinal Chemistry, 111778, 2019
2019
Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties
B Rodenak-Kladniew, SS Montoto, ML Sbaraglini, M Di Ianni, ME Ruiz, ...
International journal of pharmaceutics 569, 118575, 2019
2019
Trypanosoma cruzi virulence factors for the diagnosis of Chagas´ disease
CY Chain, DE Pires Souto, ML Sbaraglini, CA Labriola, MA Daza Millone, ...
ACS infectious diseases, 2019
2019
Design, synthesis and biological evaluation of N-substituted α-hydroxyimides and 1, 2, 3-oxathiazolidine-4-one-2, 2-dioxides with anticonvulsant activity
LL Sabatier, PH Palestro, AV Enrique, V Pastore, ML Sbaraglini, P Martín, ...
Journal of enzyme inhibition and medicinal chemistry 34 (1), 1465-1473, 2019
2019
In Silico Modeling of FDA-Approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach
CL Belllera, ML Sbaraglini, LN Alberca, JI Alice, A Talevi
In Silico Drug Design, 625-648, 2019
2019
Computer-aided search of novel inhibitors of n-myristoyl transferase with trypanocidal effects
L Alberca, M Sbaraglini, D Ruiz, SV Larrea, SF Villamil, C Carrillo, ...
International Journal of Infectious Diseases 73, 311, 2018
2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20